Furthermore, OS analysis found that high expression of ENO1 was significantly associated with poor prognosis of BLCA, BRCA, CESC, ESCC, HNSC, LIHC, LUAD, PAAD, and SARC cancers. Here, ENO1 is linked to cancer.